Industry
152d agoEli Lilly Invests $2.75B in AI Drug Development
Eli Lilly’s partnership with Insilico signals a new era for drug discovery, blending large‑scale data analytics with machine‑learning models to accelerate the identification of therapeutic candidates.
The Signal
The collaboration demonstrates how pharmaceutical giants are turning to AI to shorten development timelines and reduce costs, reshaping the global life‑sciences landscape in the competitive global market.